83/100BMSCI stock forecast 2026–2030
Analysts' average 12-month price target for MSCI is 687.70, 7.3% above the current price of 640.91. Their targets range from 615.00 to 735.00.
Of the 9 firms that rated MSCI in the past 12 months, 9 rate it buy or strong buy, 0 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 615.00 to 735.00, with an average of 687.70.
| Strong buy | 1 | |
| Buy | 8 | |
| Hold | 0 | |
| Sell | 0 | |
| Strong sell | 0 |
12-month price target
| Highest target | 735.00 |
| Average target | 687.70 |
| Lowest target | 615.00 |
| Current price | 640.91 |
MSCI price target history
Have analysts recently raised or lowered their MSCI price target and rating?
How analysts rate MSCI, month by month
9 of 9 firms rate it buy now, against 5 of 6 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
MSCI analyst upgrades, downgrades and price targets
The latest rating change came on 27 May 2026, when Wells Fargo upgraded MSCI from Equal Weight to Overweight. Its price target is 700.00, from 618.00. The most recent new target came from Morgan Stanley on 21 October 2026: 671.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 21 Oct 2026 | Morgan Stanley | Reiterated · Overweight | 700.00 → 671.00 | -4.1% | 591.69 |
| 21 Oct 2026 | Wells Fargo Jason Haas | Reiterated · Overweight | 690.00 → 720.00 | +4.3% | 591.69 |
| 21 Oct 2026 | Jefferies Surinder Thind | — | 680.00 | — | 591.69 |
| 20 Oct 2026 | Goldman Sachs George Tong | — | 684.00 | — | 591.69 |
| 20 Oct 2026 | Raymond James | — | 760.00 → 680.00 | -10.5% | 591.69 |
| 20 Oct 2026 | William Blair | — | 680.00 | — | 591.69 |
| 22 Jul 2026 | Evercore ISI | Reiterated · Outperform | 690.00 → 722.00 | +4.6% | 569.86 |
| 22 Jul 2026 | Wells Fargo | Reiterated · Overweight | 700.00 → 690.00 | -1.4% | 561.74 |
| 22 Jul 2026 | UBS | — | 638.00 → 615.00 | -3.6% | 561.74 |
| 21 Jul 2026 | Morgan Stanley Toni Kaplan | — | 700.00 | — | 561.74 |
| 10 Jul 2026 | Barclays Manav Patnaik | Reiterated · Overweight | 660.00 → 735.00 | +11.4% | 603.35 |
| 8 Jul 2026 | Raymond James Patrick O'Shaughnessy | Reiterated · Strong Buy | 730.00 → 760.00 | +4.1% | 597.24 |
| 18 Jun 2026 | Redburn Partners | — | 690.00 | — | 596.89 |
| 27 May 2026 | Wells Fargo Jason Hass | Upgraded · Equal Weight → Overweight | 618.00 → 700.00 | +13.3% | 588.52 |
| 21 Apr 2026 | Raymond James Patrick O'Shaughnessy | — | 690.00 → 730.00 | +5.8% | 589.17 |
| 17 Mar 2026 | Raymond James | Upgraded · Outperform → Strong Buy | — | — | — |
| 29 Jan 2026 | Deutsche Bank | — | 715.00 | — | 605.47 |
| 29 Jan 2026 | Evercore ISI David Motemaden | Reiterated · Outperform | 690.00 | — | 607.30 |
| 29 Jan 2026 | RBC Capital Ashish Sabadra | — | 655.00 | — | 604.54 |
| 29 Jan 2026 | Wells Fargo | Reiterated · Equal Weight | 618.00 | — | 614.87 |
| 28 Jan 2026 | UBS | — | 710.00 → 638.00 | -10.1% | 614.87 |
| 12 Jan 2026 | Raymond James Patrick O'Shaughnessy | — | 690.00 | — | 586.47 |
MSCI EPS and revenue estimates
Analysts expect MSCI's EPS to grow 18.0% a year until 2028. Over the last 5 years it grew 16.9% a year, and over the last 3 years 13.2%.
Analysts expect MSCI's revenue to grow 10.0% a year until 2028. Over the last 5 years it grew 13.1% a year, and over the last 3 years 11.7%.
Revenue
EPS
Does MSCI beat earnings estimates?
On average, analysts' EPS estimate was 3.0% off the result, either way, and their revenue estimate 1.0%, over the last 12 quarters.
- EPS beats
- 60 / 75
- Revenue beats
- 51 / 75
- Average EPS surprise, last 12
- +2.8%
- Since
- January 2008
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 20 Oct 2026 | 5.03 | 5.11 | +1.6% | 887.83M | 892.00M | +0.5% |
| Q2 FY2026 | 21 Jul 2026 | 4.99 | 4.94 | -1.0% | 870.71M | 867.00M | -0.4% |
| Q1 FY2026 | 21 Apr 2026 | 4.44 | 4.55 | +2.5% | 838.02M | 850.80M | +1.5% |
| Q4 FY2025 | 28 Jan 2026 | 4.60 | 4.66 | +1.3% | 822.43M | 822.53M | +0.0% |
| Q3 FY2025 | 28 Oct 2025 | 4.38 | 4.47 | +2.1% | 797.19M | 793.43M | -0.5% |
| Q2 FY2025 | 22 Jul 2025 | 4.15 | 4.17 | +0.5% | 770.40M | 772.68M | +0.3% |
| Q1 FY2025 | 22 Apr 2025 | 3.92 | 4.00 | +2.0% | 743.44M | 745.83M | +0.3% |
| Q4 FY2024 | 29 Jan 2025 | 3.95 | 4.18 | +5.8% | 745.44M | 743.51M | -0.3% |
| Q3 FY2024 | 29 Oct 2024 | 3.77 | 3.86 | +2.4% | 716.15M | 724.71M | +1.2% |
| Q2 FY2024 | 23 Jul 2024 | 3.55 | 3.64 | +2.5% | 696.41M | 707.95M | +1.7% |
| Q1 FY2024 | 23 Apr 2024 | 3.45 | 3.52 | +2.0% | 685.47M | 679.97M | -0.8% |
| Q4 FY2023 | 30 Jan 2024 | 3.29 | 3.68 | +11.9% | 662.73M | 690.11M | +4.1% |
MSCI stock price 2026–2030: scenarios
If MSCI's earnings keep growing at the 13.9% a year analysts expect to FY2028, it would earn about 33.22 a share in FY2030. At the P/E it has traded at over the last five years (36.8 to 69.6) that is 1,223.43 to 2,313.12 a share, or 1,537.09 at its average P/E of 46.3. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 19.70 | 725.28 | 911.23 | 1,371.27 |
| FY2027 | 22.52 | 829.21 | 1,041.81 | 1,567.78 |
| FY2028 | 25.59 | 942.37 | 1,183.98 | 1,781.72 |
| FY2029 (extrapolated) | 29.16 | 1,073.74 | 1,349.03 | 2,030.11 |
| FY2030 (extrapolated) | 33.22 | 1,223.43 | 1,537.09 | 2,313.12 |
Each year's EPS is the analysts' consensus to FY2028; the years after continue its 13.9% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (36.8, 46.3, 69.6).
Is MSCI stock undervalued or overvalued?
MSCI's P/E of 34.1 is near the bottom of its 5-year range (29.5 to 80.9, median 42.9). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. Buyers pay less for each point of growth than usual: a PEG of 1.9 on expected growth against 2.5 on its median P/E and past five years' growth. At its usual P/E (39.8 × EPS of 18.80), MSCI's fair value is 748.90; the price, 640.91, is 14.4% below it. Its forward P/E, on the consensus for FY2026, is 32.5.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (29.5 and 54.5). The price against its P/E range
- Price to earnings ratio (TTM)
- 34.09
- Five-year median P/E
- 42.87
- Five-year P/E range
- 29.5 – 80.9
- Forward P/E (FY2026)
- 32.54
- PEG ratio
- 2.45
- To the average target
- +7.3%
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 195.10146Price 99.09244 | +96.9% | |
| 186.680 | 359.93270Price 186.68450 | +92.8% | |
| 213.670 | 405.66304Price 213.67507 | +89.9% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 42.225 | 79.0244Price 42.23157 | +87.1% | |
| 160.650 | 299.85225Price 160.65375 | +86.6% | |
| 108.445 | 201.41108Price 108.45248 | +85.7% |
Furthest below the fair value on each stock's page, updated every day.